TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
DFTX

Definium Therapeutics, Inc.

Healthcare · Biotechnology · —

37.70$ -6.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow DFTX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-0.59 -0.33 -2.63 -2.31 -0.55 -1.33 -1.67 -1.62 -1.64 -0.11 -1.47
– – 0.02 0.02 0.02 – 0.10 0.10 0.08 0.00 0.00
– – – – – 0.42 1.56 0.44 0.40 0.02 0.22
0.06 0.78 -0.32 -0.07 0.55 0.12 0.07 -0.12 0.16 0.00 0.11
0.00 0.37 8.50 3.34 0.83 0.00 0.00 0.00 0.00 0.00 0.00
0.53 0.41 -14.53 1.73 -0.56 – -0.01 – – – -1.70
– – – – – – – 0.00 0.55 0.02 0.22
– 0.00 17.22 1.00 0.76 5.45 3.61 1.91 0.56 0.36 2.99
-0.06 0.07 -0.03 0.48 -0.36 4.14 1.95 0.28 -1.08 0.25 -0.18
-0.59 -0.71 -11.14 -5.65 -1.37 -1.33 -1.67 -1.62 -1.64 -0.11 -1.47

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?